Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1996 Oct;8(5):658-63.
doi: 10.1016/s0952-7915(96)80082-3.

The new vaccines: building viruses that elicit antitumor immunity

N P Restifo  1
Affiliations
Review

The new vaccines: building viruses that elicit antitumor immunity

N P Restifo. Curr Opin Immunol. 1996 Oct.

Abstract

Whereas cancer cells are poor immunogens, some viruses are capable of eliciting powerful and lifelong immunity. Recombinant viruses and plasmid DNA encoding tumor-associated antigens can elicit powerful and specific immune responses that can be enhanced by the use of cytokines and costimulatory molecules. These immune responses have destroyed growing tumor cells in experimental animal models. For the first time, immunotherapeutic strategies that employ recombinant viruses are being tested in clinical trials with cancer patients.

PubMed Disclaimer

References

    1. Coley WH. Further observations upon the treatment of malignant tumors with the toxins of erysipeler and Bacillus prodigiosus with a report of 160 cases. Bull Johns Hopkins Hosp. 1896;7:157–167.
    1. Boon T, Gajewski TF, Coulie PG. From defined human tumor antigens to effective immunization? Immunol Today. 1995;16:334–336. - PubMed
    1. Van Pel A, Van der Bruggen P, Coulie PG, Brichard VG, Lethe B, Van den Eynde B, Uyttenhove C, Renauld JC, Boon T. Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol Rev. 1995;145:229–250. - PubMed
    1. Pardoll DM. Tumour antigens. A new look for the 1990s. Nature. 1994;369:357. news; comment. - PubMed

    1. Wang M, Bronte V, Chen PW, Gritz L, Panicali D, Rosenberg SA, Restifo NP. Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. J Immunol. 1995;154:4685–4692. This paper describes a new model that can be used in the development of recombinant and synthetic anticancer vaccines. The gene encoding β-galactosidase, lacZ, transfected into the CT26 colon adenocarcinoma, comprises the experimental system in BALB/c mice. Advantages of the model include an antigen that is easy to detect (because of a unique enzymatic activity), a tumor whose growth rate and lethality are unchanged despite the transfection, and a peptide that has an identified amino acid sequence, TPHPARIGL, that is processed and presented by the Ld molecule.

LinkOut - more resources